IntegraGen
Genomic analysis & molecular diagnostics for cancer and rare diseases for researchers and labs.
ALINT | PA
Overview
Corporate Details
- ISIN(s):
- FR0010908723
- LEI:
- 969500CQD8K0BUIGDH55
- Country:
- France
- Address:
- 5 RUE HENRI DESBRUERES, 91000 EVRY-COURCOURONNES
- Website:
- https://integragen.com/
- Sector:
- Mining and quarrying
- Industry:
- Mining of non-ferrous metal ores
Description
IntegraGen, an OncoDNA group company, specializes in the genomics of cancer and rare genetic diseases. The company's mission is to translate molecular research into clinical practice through the development and commercialization of molecular diagnostic tests derived from the identification of genetic biomarkers. It provides expert genomic analysis and interpretable data services to academic researchers, private laboratories, and other life sciences organizations, aiming to advance both research and patient care.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2025-10-29 17:45 |
Earnings Release
Informations privilégiées / Communiqué sur comptes, résultats
|
French | 352.0 KB | ||
| 2025-10-06 18:30 |
Legal Proceedings Report
Informations privilégiées / Autres communiqués
|
French | 238.4 KB | ||
| 2025-04-29 18:00 |
Earnings Release
Informations privilégiées / Communiqué sur comptes, résultats
|
French | 351.8 KB | ||
| 2025-04-29 18:00 |
Earnings Release
Inside Information / News release on accounts, results
|
English | 356.4 KB | ||
| 2025-01-15 18:44 |
Earnings Release
Inside Information / Information on annual revenues
|
English | 214.4 KB | ||
| 2025-01-15 18:44 |
Earnings Release
Informations privilégiées / Information sur chiffre d’affaires annuel
|
French | 215.6 KB | ||
| 2024-10-17 18:29 |
Earnings Release
Inside Information / News release on accounts, results
|
English | 343.2 KB | ||
| 2024-10-17 18:29 |
Earnings Release
Informations privilégiées / Communiqué sur comptes, résultats
|
French | 398.7 KB | ||
| 2024-07-18 18:44 |
Earnings Release
Inside Information / Other news releases
|
English | 270.7 KB | ||
| 2024-07-18 18:44 |
Earnings Release
Informations privilégiées / Autres communiqués
|
French | 268.3 KB | ||
| 2024-04-18 18:00 |
Earnings Release
Inside Information / News release on accounts, results
|
English | 372.7 KB | ||
| 2024-04-18 18:00 |
Earnings Release
Informations privilégiées / Communiqué sur comptes, résultats
|
French | 419.4 KB | ||
| 2024-01-16 17:45 |
Earnings Release
Inside Information / Information on annual revenues
|
English | 307.9 KB | ||
| 2024-01-16 17:45 |
Earnings Release
Informations privilégiées / Information sur chiffre d’affaires annuel
|
French | 269.3 KB | ||
| 2023-10-19 18:15 |
Earnings Release
Informations privilégiées / Communiqué sur comptes, résultats
|
French | 332.6 KB |
Automate Your Workflow. Get a real-time feed of all IntegraGen filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for IntegraGen
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for IntegraGen via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
%20Co.%2C%20Ltd/other/SLSBioSpecialty_Lab_Solution_Bio_Co._Ltd-logo.jpg){kind=logo}
